Home
Investors
Sientra.com
Overview
News
Events
Financial Info
Quarterly Reports
SEC Filings
Stock Info
Quote & Chart
Analyst Coverage
Governance
Documents & Charters
Management
Board of Directors
Committee Composition
Resources
FAQs
E-mail Alerts
RSS Feeds
contact IR
News
Elieen, Actual Sientra Patient
Normal
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 16, 2019
Sientra Reports Third Quarter 2019 Financial Results
November 7, 2019
Sientra Announces Acquisition of the Independently Operated OPUS® Breast Implant Manufacturing Operation from Lubrizol Life Science
November 7, 2019
Sientra to Participate in Upcoming Investor Conferences
October 31, 2019
Sientra to Report Third Quarter 2019 Financial Results on November 7, 2019
October 17, 2019
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 17, 2019
Sientra Reports Second Quarter 2019 Financial Results
August 8, 2019
Sientra to Report Second Quarter 2019 Financial Results on August 8, 2019
July 18, 2019
Sientra, Inc. Closes $115 Million Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
June 7, 2019
Sientra Announces Pricing of Upsized Public Offering of Common Stock
June 4, 2019
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 4, 2019
Sientra Commences Public Offering of Common Stock
June 3, 2019
Sientra Reports First Quarter 2019 Financial Results
May 8, 2019
Sientra to Release First Quarter Financial Results on May 8, 2019
April 18, 2019
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
March 20, 2019
Sientra Reports Fourth Quarter and Full Year 2018 Financial Results
March 12, 2019
Sientra® to Release Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019
March 4, 2019
Sientra to Present at the 8th Annual SVB Leerink Global Healthcare Conference
February 19, 2019
Sientra Announces miraDry Leadership Transition
February 5, 2019
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 1, 2019
Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors
January 7, 2019
Nasdaq: SIEN
Stock Quote:
NASD
$
2.78
+
0.18
Volume
79,336
Previous Close
2.60
Intraday High
2.84
Intraday Low
2.60
Pricing delayed 20 minutes
Price
Change
% Change
+
6.92%
52 Week High
8.88
52 Week Low
1.25
Today's Open
2.65
Sep 29, 2023 04:00 PM
Email Alerts
Email:
*
Subscription Preferences
*
Press Release
SEC Filing
Event
EOD Stock Quote
Enter the code shown above.
Investor Contact
Sientra Investor Relations
ir@sientra.com
Privacy Statement
|
Terms of use
|
Safety
|
Compliance
|
Resources
|
Patents
|
Contact Us
|
Careers
© 2021 Sientra, Inc. All rights reserved.